Veteran entrepreneur Nihar Parikh has launched 4Point0 Health Ventures, a $75 million health-focused fund to support Indian early growth healthtech startups.
The health tech-oriented company will invest between $1 million and $2 million in early and growth-stage startups operating in the healthcare segment.
Last year Nihar Parikh sold his family business, ZCL Chemicals (formerly Zandu Chemicals) to private equity firm Advent.
Read also – Orange Health acquires diagnostic lab Rapidx
The company has backed multiple platforms so far, including Saveo, digital therapeutic startup Fitterfly, elective surgery provider Glaymo Health and healthcare digitization services provider Eka care.
Recently, Eka Care and Fitterfly had raised $15 million and $12 million respectively in series A funding round. While Saveo and Glaymo had raised funding from 4Point0 in July this year.
As a part of the investment, the fund will either be on the board of the startup or sit on its advisory committee, the company said in a statement.
About 4Point0 Health Ventures
They invest in entrepreneurs on the verge of making a breakthrough in the health-tech industry to make healthcare accessible for all. Their decades of experience in the healthcare industry has helped them understand what it takes for a new business to make their groundbreaking innovations accessible to everyone. They leverage this understanding of the healthcare landscape to add strategic value to young ventures and help them thrive.
Health 4.0 – a concept derived from the fourth manufacturing revolution (Industry 4.0), refers to the modernisation of healthcare to make it smarter and more connected using the internet of things and cloud computing.
Ultimately, it aims to use large amounts of data to make healthcare more accessible to people without the element of physical human interaction.